Increased host neuronal survival and motor function in BMT Parkinsonian mice: Involvement of immunosuppression

We examined the potential of bone marrow transplantation (BMT) to rescue dopaminergic neurons in a mouse model of Parkinson's disease (PD). A BMT from mice transgenic for green fluorescent protein (GFP+) given either before or after administration of the neurotoxin 1‐methyl‐4‐phenyl‐1,2,3,6‐tet...

Full description

Saved in:
Bibliographic Details
Published inJournal of comparative neurology (1911) Vol. 504; no. 6; pp. 690 - 701
Main Authors Keshet, Gilmor I., Tolwani, Ravi J., Trejo, Angelica, Kraft, Peggy, Doyonnas, Regis, Clayberger, Carol, Weimann, James M., Blau, Helen M.
Format Journal Article
LanguageEnglish
Published Hoboken Wiley Subscription Services, Inc., A Wiley Company 20.10.2007
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:We examined the potential of bone marrow transplantation (BMT) to rescue dopaminergic neurons in a mouse model of Parkinson's disease (PD). A BMT from mice transgenic for green fluorescent protein (GFP+) given either before or after administration of the neurotoxin 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP) led to the accumulation of transplanted adult GFP+ bone‐marrow‐derived cells (BMDC) in the substantia nigra, where dopaminergic neurodegeneration occurs in PD. Post‐BMT, mice exposed to MPTP had substantially greater numbers of endogenous tyrosine hydroxylase‐positive neuronal cell bodies in the substantia nigra and increased dopamine transporter‐positive projections into the striatum compared to controls. Moreover, motor function was restored to normal within 1 month post‐MPTP in BMT‐treated mice assayed by a rotarod behavioral test. The effect of BMT on PD was indirect, as no evidence of BMDC fusion with or transdifferentiation into dopaminergic neurons was observed. BMDC activated by BMT or associated factors could play a trophic role in rescuing damaged cells. Alternatively, the beneficial effects of BMT are due to immunosuppression reflected by a reduction in the proportion of T‐cells and a reduction of T‐cell proliferation in BMT mice. These findings highlight that when immunosuppression is required for transplantation studies, the amelioration of symptoms may not be due to the transplant itself. Further, they suggest that the immune system plays a role in the development of characteristics typical of PD. J. Comp. Neurol. 504:690–701, 2007. © 2007 Wiley‐Liss, Inc.
Bibliography:ark:/67375/WNG-D005G9G6-L
istex:CDF1537AA5D5356C9949B7B7F0C212751DAAC613
ArticleID:CNE21483
Ellison Foundation - No. AG09521; No. AG20961; No. HL65572; No. HD18179
National Institutes of Health (NIH) - No. NIH K01-RR00129
Baxter Foundation - No. AG-SS-0817-01
ISSN:0021-9967
1096-9861
DOI:10.1002/cne.21483